[go: up one dir, main page]

Latest News for: dna polymerase

Edit

Artios Receives U.S. FDA Fast Track Designation for DNA Polymerase Theta (Polθ) Inhibitor ART6043 for Treatment of gBRCA-mutated HER2-Negative Breast Cancer (IP Group plc)

Public Technologies 24 Feb 2026
Its three potentially first-in-class programs, each with a novel mechanism of action, include ATR inhibitor alnodesertib, the DNA polymerase theta (Polθ) inhibitor ART6043, and a preclinical portfolio of DDRi-ADC candidates with novel payloads.
Edit

Artios Receives U.S. FDA Fast Track Designation for DNA Polymerase Theta (Polθ) Inhibitor ART6043 for ...

Nasdaq Globe Newswire 23 Feb 2026
Artios receives FDA Fast Track designation for DNA polymerase theta (Polθ) inhibitor ART6043 for treatment of gBRCA-mutated HER2-negative breast cancer ... .
Edit

USPTO Grants Acurx Pharmaceuticals New Patent for DNA Polymerase IIIC Inhibitors

PR Newswire 02 Feb 2026
patents, along with granted patents in Israel, Japan, India, and Australia, all of which protect key aspects of the Company's ACX‑375C program targeting DNA Polymerase IIIC.
Edit

Correction for Tian et al., DNA polymerase delta governs parental histone transfer to DNA replication ...

PNAS 20 Jan 2026
Proceedings of the National Academy of Sciences, Volume 123, Issue 4, January 2026 ... .
Edit

Reference 25 - Saiki RK, Gelfand DH, Stoffel S, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988 (The eRulemaking Program)

Public Technologies 25 Nov 2025
). The text version of this document is not available ... Disclaimer ... (noodl. 127954810) .
  • 1

Article Search

tools
×
×
×
×